Patented Medicines (Notice of Compliance) Regulations Matter Relating to a Methylphenidate Product
Janssen-Ortho Inc. v. Apotex Inc., 2010 FC 82 (Zinn, J.)

January 25, 2010

Neil Belmore for the Applicants, Janssen-Ortho Inc. and Alza Corporation
David Lederman and Daniel Cappe for the Respondent, Apotex Inc. (“Apotex”)

This decision relates to an application under the Patented Medicines (Notice of Compliance) Regulations which was consolidated with the application reported in 2010 FC 81.  Separate reasons for the order were given, but the reasons are identical.  Therefore, the case summary for 2010 FC 82 is applicable to this decision. 

By: Jacqueline Chernys